Most recently, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a big selection of endogenous opioids. In contrast to most opioid receptors, this receptor functions as a scavenger https://josephz812shx1.techionblog.com/profile